Author:
Kim Byung-Tae,Kim E. Edmund
Reference22 articles.
1. Dienstag JL, Isselbacher K. Tumors of the liver and biliary tract. In: Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL, eds. Harrison’s Principles of Internal Medicine, 15th ed. New York: McGraw-Hill, 1998: 588–591.
2. Fukuda H, Matsuzawa T, Abe Y, et al. Experimental study for cancer diagnosis with positron-labeled fluorinated glucose analogs: [18F]-2-fluoro2-deoxy-D-mannose: a new tracer for cancer detection. Eur J Nucl Med 1982; 7: 294–297.
3. Yonekura Y, Benua RS, Brill AB, et al. Increased accumulation of 2-deoxy2-[18F]fluoro-D-glucose in liver metastases from colon carcinoma. J Nucl Med 1982; 23: 1133–1137.
4. Paul R, Ahonen A, Roeda D, Nordman E. Imaging of hepatoma with 18Ffluorodeoxyglucose. Lancet 1985; 1 (8419): 50–51.
5. Nagata Y, Yamamoto K, Hiraoka M, et al. Monitoring liver tumor therapy with [18F]FDG positron emission tomography. J Comput Assist Tomogr 1990; 14: 370–374.